Longitudinal study of covid-19 antibody response in children in seattle WA
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30120C08325
- Awardee
-
Seattle Children's Hospital UEI SZ32VTCXM799
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $2,304,624
Award facts
- Opportunity
-
- 75D30120Q71936 Solicitation number
- Contract value 100% obligated
- $2,304,624.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 100 offers Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Seattle, WA 98105, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $953,923 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $541,048 | |
| Original award | $809,653 |
About this award
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Seattle Children's Hospital, a non-profit healthcare provider, to conduct a longitudinal study on COVID-19 antibody response in children in Seattle, Washington. The $2,304,624 definitive contract, awarded on June 12, 2020, does not have a set-aside designation and is scheduled for completion by January 31, 2024.
As the prime contractor, Seattle Children's Hospital has subcontracted with the Fred Hutchinson Cancer Research Center to perform specific tasks related to the study, such as running neutralization assays and ELISA tests. Fred Hutchinson is a non-profit research organization that has a history of supporting various federal research initiatives through both prime contracts and subcontracts.
The longitudinal study aims to provide insights into the immune response of children to COVID-19, which can inform public health strategies and clinical practices. This contract award is part of the CDC's broader efforts to understand the epidemiology and impact of the COVID-19 pandemic.
Quick answers
Who was awarded contract 75D30120C08325?
75D30120C08325 was awarded to Seattle Children's Hospital by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 12, 2020.
How much is contract 75D30120C08325 worth?
The government has obligated $2,304,624 on 75D30120C08325.
Was contract 75D30120C08325 competed?
The extent of competition for 75D30120C08325 was full and open competition. The government received 100 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award